GlassScriptPhysician profile
Rodney Siau
NPI 1639216344
$12,949.18
in general payments reported to CMS, 2019-2025
37 companies · $1,878 in 2025
The $1,878 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,737 · 2022: $1,879 · 2023: $2,677 · 2024: $2,778 · 2025: $1,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,323 · Education: $9.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,322.93 |
| Education | $9.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,898.69 | 2021-2024 | Axonics |
| Medtronic, INC. | $1,964.14 | 2021-2025 | Interstim, Altaviva |
| Sumitomo Pharma America, INC. | $967.94 | 2023-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $749.77 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $670.93 | 2021-2025 | |
| Astellas Pharma US INC | $585.35 | 2021-2025 | Veozah, Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $567.23 | 2021-2025 | Erleada, Akeega, Balversa |
| Dendreon Pharmaceuticals LLC | $413.51 | 2022-2025 | Provenge |
| Myovant Sciences INC. | $371.99 | 2021-2022 | |
| Antares Pharma, INC. | $356.60 | 2021-2025 | Xyosted, Nocdurna, Tlando |
| Endo Pharmaceuticals INC. | $335.03 | 2021-2024 | Xiaflex, Aveed |
| Urogen Pharma, INC. | $326.30 | 2025 | |
| Accord Healthcare, INC. | $321.83 | 2024-2025 | |
| Teleflex LLC | $295.04 | 2023-2025 | Barrigel, Urolift |
| Myriad Genetic Laboratories, INC. | $295.02 | 2023-2025 | Prolaris |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $264.08 | 2021-2025 | |
| Urovant Sciences INC | $233.75 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $230.01 | 2021-2023 | Lynparza |
| Procept Biorobotics Corporation | $215.69 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Merck Sharp & Dohme LLC | $206.64 | 2022-2024 | Keytruda, Lynparza |
| Amgen INC. | $88.07 | 2021-2022 | |
| Boston Scientific Corporation | $86.80 | 2021-2023 | Rezum Generator, Ams 700 Cxr Rte Kit |
| Halozyme INC | $79.80 | 2023 | |
| Endo USA, INC. | $72.54 | 2024-2025 | Xiaflex |
| 180 Medical, INC. | $56.41 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $53.25 | 2021-2023 | Yonsa |
| Convatec INC. | $36.70 | 2024 | |
| Tolmar, INC. | $35.35 | 2023-2024 | |
| Allergan, INC. | $34.03 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.21 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $18.57 | 2022 | |
| Verity Pharmaceuticals INC. | $18.38 | 2025 | Tlando |
| Calyxo, INC. | $17.42 | 2025 | Cvac Aspiration System |
| Blue Earth Diagnostics | $16.55 | 2021 | |
| Lilly USA, LLC | $15.80 | 2024 | Zepbound |
| Acerus Pharmaceuticals Corporation | $13.66 | 2022 | |
| Laborie Medical Technologies Corp. | $13.10 | 2024 | Urgent PC Neuromodulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Siau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.